Justin Quion
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Justin Quion has a total of 100 co-authors. Here are the top co-authors by number of shared publications:
- Leo Anthony Celi
Laboratory for Computational Physiology, Massachusetts Institute of Technology
5 shared publications - David Restrepo
Massachusetts Institute of Technology USA
3 shared publications Adam Lacy-Hulbert
Affiliation Department of Systems Immunology, Benaroya Research Institute at Virginia Mason, Seattle, Washington, United States of America
2 shared publications- Adrian Velasquez
Affiliations Department of Medicine, Carney Hospital, Boston, Massachusetts, United States of America, Warren Alpert School of Medicine at Brown University, Providence, Rhode Island, United States of America
2 shared publications - Alexandra Weissman
Department of Emergency Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
2 shared publications Ali Lahooti
Affiliation Department of Gastroenterology and Hepatology, Weill Cornell Medical College, New York, New York, United States of America
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 24 February 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (2) , e1004432
A systematic review of machine learning-based prognostic models for acute pancreatitis: Towards improving methods and reporting quality
Background: An accurate prognostic tool is essential to aid clinical decision-making (e.g., patient triage) and to advance personalized medicine. However, such a prognostic tool is lacking for acute pancreatitis (AP). Increasingly machine learning (ML) techniques are being used to develop high-performing prognostic models in AP. However, methodologic and reporting quality has received little attention. High-quality reporting and study methodology are critical for model validity, reproducibility, and clinical implementation. In collaboration with content experts in ML methodology, we performed a systematic review critically appraising the quality of methodology and reporting of recently published ML AP prognostic models. Methods/findings: Using a validated search strategy, we identified ML AP studies from the databases MEDLINE and EMBASE published between January 2021 and December 2023. We also searched pre-print servers medRxiv, bioRxiv, and arXiv for pre-prints registered between January 2021 and December 2023. Eligibility criteria included all retrospective or prospective studies that developed or validated new or existing ML models in patients with AP that predicted an outcome following an episode of AP. Meta-analysis was considered if there was homogeneity in the study design and in the type of outcome predicted. For risk of bias (ROB) assessment, we used the Prediction Model Risk of Bias Assessment Tool. Quality of reporting was assessed using the Transparent Reporting of a Multivariable Prediction Model of Individual Prognosis or Diagnosis—Artificial Intelligence (TRIPOD+AI) statement that defines standards for 27 items that should be reported in publications using ML prognostic models. The search strategy identified 6,480 publications of which 30 met the eligibility criteria. Studies originated from China (22), the United States (4), and other (4). All 30 studies developed a new ML model and none sought to validate an existing ML model, producing a total of 39 new ML models. AP severity (23/39) or mortality (6/39) were the most common outcomes predicted. The mean area under the curve for all models and endpoints was 0.91 (SD 0.08). The ROB was high for at least one domain in all 39 models, particularly for the analysis domain (37/39 models). Steps were not taken to minimize over-optimistic model performance in 27/39 models. Due to heterogeneity in the study design and in how the outcomes were defined and determined, meta-analysis was not performed. Studies reported on only 15/27 items from TRIPOD+AI standards, with only 7/30 justifying sample size and 13/30 assessing data quality. Other reporting deficiencies included omissions regarding human–AI interaction (28/30), handling low-quality or incomplete data in practice (27/30), sharing analytical codes (25/30), study protocols (25/30), and reporting source data (19/30). Conclusions: There are significant deficiencies in the methodology and reporting of recently published ML based prognostic models in AP patients. These undermine the validity, reproducibility, and implementation of these prognostic models despite their promise of superior predictive accuracy. Registration: Research Registry (reviewregistry1727)
- 24 February 2025
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 22 (2) , e1004432
Top Cited PapersOpen AccessA systematic review of machine learning-based prognostic models for acute pancreatitis: Towards improving methods and reporting quality
Background: An accurate prognostic tool is essential to aid clinical decision-making (e.g., patient triage) and to advance personalized medicine. However, such a prognostic tool is lacking for acute pancreatitis (AP). Increasingly machine learning (ML) techniques are being used to develop high-performing prognostic models in AP. However, methodologic and reporting quality has received little attention. High-quality reporting and study methodology are critical for model validity, reproducibility, and clinical implementation. In collaboration with content experts in ML methodology, we performed a systematic review critically appraising the quality of methodology and reporting of recently published ML AP prognostic models. Methods/findings: Using a validated search strategy, we identified ML AP studies from the databases MEDLINE and EMBASE published between January 2021 and December 2023. We also searched pre-print servers medRxiv, bioRxiv, and arXiv for pre-prints registered between January 2021 and December 2023. Eligibility criteria included all retrospective or prospective studies that developed or validated new or existing ML models in patients with AP that predicted an outcome following an episode of AP. Meta-analysis was considered if there was homogeneity in the study design and in the type of outcome predicted. For risk of bias (ROB) assessment, we used the Prediction Model Risk of Bias Assessment Tool. Quality of reporting was assessed using the Transparent Reporting of a Multivariable Prediction Model of Individual Prognosis or Diagnosis—Artificial Intelligence (TRIPOD+AI) statement that defines standards for 27 items that should be reported in publications using ML prognostic models. The search strategy identified 6,480 publications of which 30 met the eligibility criteria. Studies originated from China (22), the United States (4), and other (4). All 30 studies developed a new ML model and none sought to validate an existing ML model, producing a total of 39 new ML models. AP severity (23/39) or mortality (6/39) were the most common outcomes predicted. The mean area under the curve for all models and endpoints was 0.91 (SD 0.08). The ROB was high for at least one domain in all 39 models, particularly for the analysis domain (37/39 models). Steps were not taken to minimize over-optimistic model performance in 27/39 models. Due to heterogeneity in the study design and in how the outcomes were defined and determined, meta-analysis was not performed. Studies reported on only 15/27 items from TRIPOD+AI standards, with only 7/30 justifying sample size and 13/30 assessing data quality. Other reporting deficiencies included omissions regarding human–AI interaction (28/30), handling low-quality or incomplete data in practice (27/30), sharing analytical codes (25/30), study protocols (25/30), and reporting source data (19/30). Conclusions: There are significant deficiencies in the methodology and reporting of recently published ML based prognostic models in AP patients. These undermine the validity, reproducibility, and implementation of these prognostic models despite their promise of superior predictive accuracy. Registration: Research Registry (reviewregistry1727)
- Open Access
A Systematic Review of Machine Learning-based Prognostic Models for Acute Pancreatitis: Towards Improving Methods and Reporting Quality
Background: An accurate prognostic tool is essential to aid clinical decision making (e.g., patient triage) and to advance personalized medicine. However, such prognostic tool is lacking for acute pancreatitis (AP). Increasingly machine learning (ML) techniques are being used to develop high-performing prognostic models in AP. However, methodologic and reporting quality has received little attention . High-quality reporting and study methodology are critical to model validity, reproducibility, and clinical implementation. In collaboration with content experts in ML methodology, we performed a systematic review critically appraising the quality of methodology and reporting of recently published ML AP prognostic models. Methods: Using a validated search strategy, we identified ML AP studies from the databases MEDLINE, PubMed, and EMBASE published between January 2021 and December 2023. Eligibility criteria included all retrospective or prospective studies that developed or validated new or existing ML models in patients with AP that predicted an outcome following an episode of AP. Meta-analysis was considered if there was homogeneity in the study design and in the type of outcome predicted. For risk of bias (ROB) assessment, we used the Prediction Model Risk of Bias Assessment Tool (PROBAST). Quality of reporting was assessed using the Transparent Reporting of a Multivariable Prediction Model of Individual Prognosis or Diagnosis – Artificial Intelligence (TRIPOD+AI) statement that defines standards for 27 items that should be reported in publications using ML prognostic models. Results: The search strategy identified 6480 publications of which 30 met the eligibility criteria. Studies originated from China (22), U.S (4), and other (4). All 30 studies developed a new ML model and none sought to validate an existing ML model, producing a total of 39 new ML models. AP severity (23/39) or mortality (6/39) were the most common outcomes predicted. The mean area-under-the-curve for all models and endpoints was 0.91 (SD 0.08). The ROB was high for at least one domain in all 39 models, particularly for the analysis domain (37/39 models). Steps were not taken to minimize over-optimistic model performance in 27/39 models. Due to heterogeneity in the study design and in how the outcomes were defined and determined, meta-analysis was not performed. Studies reported on only 15/27 items from TRIPOD+AI standards, with only 7/30 justifying sample size and 13/30 assessing data quality. Other reporting deficiencies included omissions regarding human-AI interaction (28/30), handling low-quality or incomplete data in practice (27/30), sharing analytical codes (25/30), study protocols (25/30) and reporting source data (19/30),. Discussion: There are significant deficiencies in the methodology and reporting of recently published ML based prognostic models in AP patients. These undermine the validity, reproducibility and implementation of these prognostic models despite their promise of superior predictive accuracy. Funding: none Registration: Research Registry ( reviewregistry1727 )
Open AccessA Systematic Review of Machine Learning-based Prognostic Models for Acute Pancreatitis: Towards Improving Methods and Reporting Quality
Background: An accurate prognostic tool is essential to aid clinical decision making (e.g., patient triage) and to advance personalized medicine. However, such prognostic tool is lacking for acute pancreatitis (AP). Increasingly machine learning (ML) techniques are being used to develop high-performing prognostic models in AP. However, methodologic and reporting quality has received little attention . High-quality reporting and study methodology are critical to model validity, reproducibility, and clinical implementation. In collaboration with content experts in ML methodology, we performed a systematic review critically appraising the quality of methodology and reporting of recently published ML AP prognostic models. Methods: Using a validated search strategy, we identified ML AP studies from the databases MEDLINE, PubMed, and EMBASE published between January 2021 and December 2023. Eligibility criteria included all retrospective or prospective studies that developed or validated new or existing ML models in patients with AP that predicted an outcome following an episode of AP. Meta-analysis was considered if there was homogeneity in the study design and in the type of outcome predicted. For risk of bias (ROB) assessment, we used the Prediction Model Risk of Bias Assessment Tool (PROBAST). Quality of reporting was assessed using the Transparent Reporting of a Multivariable Prediction Model of Individual Prognosis or Diagnosis – Artificial Intelligence (TRIPOD+AI) statement that defines standards for 27 items that should be reported in publications using ML prognostic models. Results: The search strategy identified 6480 publications of which 30 met the eligibility criteria. Studies originated from China (22), U.S (4), and other (4). All 30 studies developed a new ML model and none sought to validate an existing ML model, producing a total of 39 new ML models. AP severity (23/39) or mortality (6/39) were the most common outcomes predicted. The mean area-under-the-curve for all models and endpoints was 0.91 (SD 0.08). The ROB was high for at least one domain in all 39 models, particularly for the analysis domain (37/39 models). Steps were not taken to minimize over-optimistic model performance in 27/39 models. Due to heterogeneity in the study design and in how the outcomes were defined and determined, meta-analysis was not performed. Studies reported on only 15/27 items from TRIPOD+AI standards, with only 7/30 justifying sample size and 13/30 assessing data quality. Other reporting deficiencies included omissions regarding human-AI interaction (28/30), handling low-quality or incomplete data in practice (27/30), sharing analytical codes (25/30), study protocols (25/30) and reporting source data (19/30),. Discussion: There are significant deficiencies in the methodology and reporting of recently published ML based prognostic models in AP patients. These undermine the validity, reproducibility and implementation of these prognostic models despite their promise of superior predictive accuracy. Funding: none Registration: Research Registry ( reviewregistry1727 )
- Open Access
- 19 January 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (1) , e0002513
A scientometric analysis of fairness in health AI literature
Artificial intelligence (AI) and machine learning are central components of today’s medical environment. The fairness of AI, i.e. the ability of AI to be free from bias, has repeatedly come into question. This study investigates the diversity of members of academia whose scholarship poses questions about the fairness of AI. The articles that combine the topics of fairness, artificial intelligence, and medicine were selected from Pubmed, Google Scholar, and Embase using keywords. Eligibility and data extraction from the articles were done manually and cross-checked by another author for accuracy. Articles were selected for further analysis, cleaned, and organized in Microsoft Excel; spatial diagrams were generated using Public Tableau. Additional graphs were generated using Matplotlib and Seaborn. Linear and logistic regressions were conducted using Python to measure the relationship between funding status, number of citations, and the gender demographics of the authorship team. We identified 375 eligible publications, including research and review articles concerning AI and fairness in healthcare. Analysis of the bibliographic data revealed that there is an overrepresentation of authors that are white, male, and are from high-income countries, especially in the roles of first and last author. Additionally, analysis showed that papers whose authors are based in higher-income countries were more likely to be cited more often and published in higher impact journals. These findings highlight the lack of diversity among the authors in the AI fairness community whose work gains the largest readership, potentially compromising the very impartiality that the AI fairness community is working towards.
- 19 January 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (1) , e0002513
Open AccessA scientometric analysis of fairness in health AI literature
Artificial intelligence (AI) and machine learning are central components of today’s medical environment. The fairness of AI, i.e. the ability of AI to be free from bias, has repeatedly come into question. This study investigates the diversity of members of academia whose scholarship poses questions about the fairness of AI. The articles that combine the topics of fairness, artificial intelligence, and medicine were selected from Pubmed, Google Scholar, and Embase using keywords. Eligibility and data extraction from the articles were done manually and cross-checked by another author for accuracy. Articles were selected for further analysis, cleaned, and organized in Microsoft Excel; spatial diagrams were generated using Public Tableau. Additional graphs were generated using Matplotlib and Seaborn. Linear and logistic regressions were conducted using Python to measure the relationship between funding status, number of citations, and the gender demographics of the authorship team. We identified 375 eligible publications, including research and review articles concerning AI and fairness in healthcare. Analysis of the bibliographic data revealed that there is an overrepresentation of authors that are white, male, and are from high-income countries, especially in the roles of first and last author. Additionally, analysis showed that papers whose authors are based in higher-income countries were more likely to be cited more often and published in higher impact journals. These findings highlight the lack of diversity among the authors in the AI fairness community whose work gains the largest readership, potentially compromising the very impartiality that the AI fairness community is working towards.
- Open Access
- 25 October 2023
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 2 (10) , e0000368
A scoping review of the landscape of health-related open datasets in Latin America
Artificial intelligence (AI) algorithms have the potential to revolutionize healthcare, but their successful translation into clinical practice has been limited. One crucial factor is the data used to train these algorithms, which must be representative of the population. However, most healthcare databases are derived from high-income countries, leading to non-representative models and potentially exacerbating health inequities. This review focuses on the landscape of health-related open datasets in Latin America, aiming to identify existing datasets, examine data-sharing frameworks, techniques, platforms, and formats, and identify best practices in Latin America. The review found 61 datasets from 23 countries, with the DATASUS dataset from Brazil contributing to the majority of articles. The analysis revealed a dearth of datasets created by the authors themselves, indicating a reliance on existing open datasets. The findings underscore the importance of promoting open data in Latin America. We provide recommendations for enhancing data sharing in the region.
- 25 October 2023
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 2 (10) , e0000368
Open AccessA scoping review of the landscape of health-related open datasets in Latin America
Artificial intelligence (AI) algorithms have the potential to revolutionize healthcare, but their successful translation into clinical practice has been limited. One crucial factor is the data used to train these algorithms, which must be representative of the population. However, most healthcare databases are derived from high-income countries, leading to non-representative models and potentially exacerbating health inequities. This review focuses on the landscape of health-related open datasets in Latin America, aiming to identify existing datasets, examine data-sharing frameworks, techniques, platforms, and formats, and identify best practices in Latin America. The review found 61 datasets from 23 countries, with the DATASUS dataset from Brazil contributing to the majority of articles. The analysis revealed a dearth of datasets created by the authors themselves, indicating a reliance on existing open datasets. The findings underscore the importance of promoting open data in Latin America. We provide recommendations for enhancing data sharing in the region.
- Open Access
Participant Flow Diagrams for Health Equity in AI Research
Biases in sample creation can arise at any study phase, including initial patient recruitment, exclusion criteria, input-level exclusion and outcome-level exclusion, and often reflect the underrepresentation or exclusion of demographic groups historically disadvantaged in medical research. The use of non-representative samples to construct clinical algorithms in artificial intelligence (AI) and machine learning (ML) applications may further amplify this selection bias. Building on the “Data Cards” initiative for transparency in AI research, we advocate for the addition of a detailed participant flow diagram for AI studies, emphasizing the need to detail excluded participant demographic characteristics at every study phase. This tracking of excluded participants enhances understanding of potential algorithmic biases before their clinical implementation, and thus deserves to be detailed in any medical AI study. We include both a model for this flow diagram as well as a brief case study explaining how it could be implemented in practice. Through standardized reporting of participant flow diagrams, we can better gauge the potential inequity embedded in AI applications, facilitating more reliable and equitable clinical algorithms.
Open AccessParticipant Flow Diagrams for Health Equity in AI Research
Biases in sample creation can arise at any study phase, including initial patient recruitment, exclusion criteria, input-level exclusion and outcome-level exclusion, and often reflect the underrepresentation or exclusion of demographic groups historically disadvantaged in medical research. The use of non-representative samples to construct clinical algorithms in artificial intelligence (AI) and machine learning (ML) applications may further amplify this selection bias. Building on the “Data Cards” initiative for transparency in AI research, we advocate for the addition of a detailed participant flow diagram for AI studies, emphasizing the need to detail excluded participant demographic characteristics at every study phase. This tracking of excluded participants enhances understanding of potential algorithmic biases before their clinical implementation, and thus deserves to be detailed in any medical AI study. We include both a model for this flow diagram as well as a brief case study explaining how it could be implemented in practice. Through standardized reporting of participant flow diagrams, we can better gauge the potential inequity embedded in AI applications, facilitating more reliable and equitable clinical algorithms.
- Open Access
- 14 August 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (8) , e0002252
A new tool for evaluating health equity in academic journals; the Diversity Factor
Current methods to evaluate a journal’s impact rely on the downstream citation mapping used to generate the Impact Factor. This approach is a fragile metric prone to being skewed by outlier values and does not speak to a researcher’s contribution to furthering health outcomes for all populations. Therefore, we propose the implementation of a Diversity Factor to fulfill this need and supplement the current metrics. It is composed of four key elements: dataset properties, author country, author gender and departmental affiliation. Due to the significance of each individual element, they should be assessed independently of each other as opposed to being combined into a simplified score to be optimized. Herein, we discuss the necessity of such metrics, provide a framework to build upon, evaluate the current landscape through the lens of each key element and publish the findings on a freely available website that enables further evaluation. The OpenAlex database was used to extract the metadata of all papers published from 2000 until August 2022, and Natural language processing was used to identify individual elements. Features were then displayed individually on a static dashboard developed using TableauPublic, which is available at www.equitablescience.com. In total, 130,721 papers were identified from 7,462 journals where significant underrepresentation of LMIC and Female authors was demonstrated. These findings are pervasive and show no positive correlation with the Journal’s Impact Factor. The systematic collection of the Diversity Factor concept would allow for more detailed analysis, highlight gaps in knowledge, and reflect confidence in the translation of related research. Conversion of this metric to an active pipeline would account for the fact that how we define those most at risk will change over time and quantify responses to particular initiatives. Therefore, continuous measurement of outcomes across groups and those investigating those outcomes will never lose importance. Moving forward, we encourage further revision and improvement by diverse author groups in order to better refine this concept.
- 14 August 2023
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 3 (8) , e0002252
Open AccessA new tool for evaluating health equity in academic journals; the Diversity Factor
Current methods to evaluate a journal’s impact rely on the downstream citation mapping used to generate the Impact Factor. This approach is a fragile metric prone to being skewed by outlier values and does not speak to a researcher’s contribution to furthering health outcomes for all populations. Therefore, we propose the implementation of a Diversity Factor to fulfill this need and supplement the current metrics. It is composed of four key elements: dataset properties, author country, author gender and departmental affiliation. Due to the significance of each individual element, they should be assessed independently of each other as opposed to being combined into a simplified score to be optimized. Herein, we discuss the necessity of such metrics, provide a framework to build upon, evaluate the current landscape through the lens of each key element and publish the findings on a freely available website that enables further evaluation. The OpenAlex database was used to extract the metadata of all papers published from 2000 until August 2022, and Natural language processing was used to identify individual elements. Features were then displayed individually on a static dashboard developed using TableauPublic, which is available at www.equitablescience.com. In total, 130,721 papers were identified from 7,462 journals where significant underrepresentation of LMIC and Female authors was demonstrated. These findings are pervasive and show no positive correlation with the Journal’s Impact Factor. The systematic collection of the Diversity Factor concept would allow for more detailed analysis, highlight gaps in knowledge, and reflect confidence in the translation of related research. Conversion of this metric to an active pipeline would account for the fact that how we define those most at risk will change over time and quantify responses to particular initiatives. Therefore, continuous measurement of outcomes across groups and those investigating those outcomes will never lose importance. Moving forward, we encourage further revision and improvement by diverse author groups in order to better refine this concept.
- Open Access
Who does the fairness in health AI community represent?
OBJECTIVE: Artificial intelligence (AI) and machine learning are central components of today’s medical environment. The fairness of AI, i.e. the ability of AI to be free from bias, has repeatedly come into question. This study investigates the diversity of the members of academia whose scholarship poses questions about the fairness of AI. METHODS: The articles that combine the topics of fairness, artificial intelligence, and medicine were selected from Pubmed, Google Scholar, and Embase using keywords. Eligibility and data extraction from the articles were done manually and cross-checked by another author for accuracy. 375 articles were selected for further analysis, cleaned, and organized in Microsoft Excel; spatial diagrams were generated using Public Tableau. Additional graphs were generated using Matplotlib and Seaborn. The linear and logistic regressions were analyzed using Python. RESULTS: We identified 375 eligible publications, including research and review articles concerning AI and fairness in healthcare. When looking at the demographics of all authors, out of 1984, 794 were female, and 1190 were male. Out of 375 first authors, 155 (41.33%) were female, and 220 (58.67%) were male. For last authors 110 (31.16%) were female, and 243 (68.84%) were male. In regards to ethnicity, 234 (62.40%) of the first authors were white, 103 (27.47%) were Asian, 24 (6.40%) were black, and 14 (3.73%) were Hispanic. For the last authors, 234 (66.29%) were white, 96 (27.20%) were Asian, 12 (3.40%) were black, and 11 (3.11%) were Hispanic. Most authors were from the USA, Canada, and the United Kingdom. The trend continued for the first and last authors of the articles. When looking at the general distribution, 1631 (82.2%) were based in high-income countries, 209 (10.5 %) were based in upper-middle-income countries, 135 (6.8%) were based in lower-middle-income countries, and 9 (0.5 %) were based in low-income countries. CONCLUSIONS: Analysis of the bibliographic data revealed that there is an overrepresentation of white authors and male authors, especially in the roles of first and last author. The more male authors a paper had the more likely they were to be cited. Additionally, analysis showed that papers whose authors are based in higher-income countries were more likely to be cited more often and published in higher impact journals. These findings highlight the lack of diversity among the authors in the AI fairness community whose work gains the largest readership, potentially compromising the very impartiality that the AI fairness community is working towards.
Open AccessWho does the fairness in health AI community represent?
OBJECTIVE: Artificial intelligence (AI) and machine learning are central components of today’s medical environment. The fairness of AI, i.e. the ability of AI to be free from bias, has repeatedly come into question. This study investigates the diversity of the members of academia whose scholarship poses questions about the fairness of AI. METHODS: The articles that combine the topics of fairness, artificial intelligence, and medicine were selected from Pubmed, Google Scholar, and Embase using keywords. Eligibility and data extraction from the articles were done manually and cross-checked by another author for accuracy. 375 articles were selected for further analysis, cleaned, and organized in Microsoft Excel; spatial diagrams were generated using Public Tableau. Additional graphs were generated using Matplotlib and Seaborn. The linear and logistic regressions were analyzed using Python. RESULTS: We identified 375 eligible publications, including research and review articles concerning AI and fairness in healthcare. When looking at the demographics of all authors, out of 1984, 794 were female, and 1190 were male. Out of 375 first authors, 155 (41.33%) were female, and 220 (58.67%) were male. For last authors 110 (31.16%) were female, and 243 (68.84%) were male. In regards to ethnicity, 234 (62.40%) of the first authors were white, 103 (27.47%) were Asian, 24 (6.40%) were black, and 14 (3.73%) were Hispanic. For the last authors, 234 (66.29%) were white, 96 (27.20%) were Asian, 12 (3.40%) were black, and 11 (3.11%) were Hispanic. Most authors were from the USA, Canada, and the United Kingdom. The trend continued for the first and last authors of the articles. When looking at the general distribution, 1631 (82.2%) were based in high-income countries, 209 (10.5 %) were based in upper-middle-income countries, 135 (6.8%) were based in lower-middle-income countries, and 9 (0.5 %) were based in low-income countries. CONCLUSIONS: Analysis of the bibliographic data revealed that there is an overrepresentation of white authors and male authors, especially in the roles of first and last author. The more male authors a paper had the more likely they were to be cited. Additionally, analysis showed that papers whose authors are based in higher-income countries were more likely to be cited more often and published in higher impact journals. These findings highlight the lack of diversity among the authors in the AI fairness community whose work gains the largest readership, potentially compromising the very impartiality that the AI fairness community is working towards.